Replies to post #10262 on MannKind Corp. (MNKD)

[TREND1]

*** Phaeton
The market is in the process of correcting this failure called Afrezza.
As more and more doctor's agree with the FDA report that Afrezza
does not help in lowering A1C, it will be taken off the market
in JAN 2016.
But readers of this board will know the truth when the new RX'S
of Afrezza fall below Exubera's trend.

Only 3 more weeks to go.
.